H. Bartelink

959 total citations · 1 hit paper
35 papers, 763 citations indexed

About

H. Bartelink is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, H. Bartelink has authored 35 papers receiving a total of 763 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cancer Research, 15 papers in Oncology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in H. Bartelink's work include Breast Cancer Treatment Studies (15 papers), Advances in Oncology and Radiotherapy (5 papers) and Colorectal Cancer Surgical Treatments (4 papers). H. Bartelink is often cited by papers focused on Breast Cancer Treatment Studies (15 papers), Advances in Oncology and Radiotherapy (5 papers) and Colorectal Cancer Surgical Treatments (4 papers). H. Bartelink collaborates with scholars based in Netherlands, France and United States. H. Bartelink's co-authors include E. A. van Slooten, A. A. M. Hart, G. B. Snow, van Dongen Ja, W. Van den Bogaert, Alain Fourquet, Geertjan van Tienhoven, Kjell Arne Johansson, G. Garavaglia and B.J. Mijnheer and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

H. Bartelink

33 papers receiving 738 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic factors of neck node metastasis

1982 372 citations H. Bartelink et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H. Bartelink Netherlands	10	394	387	330	266	147	35	763
Jean‐Paul Le Bourgeois France	12	222 0.6×	193 0.5×	167 0.5×	122 0.5×	78 0.5×	15	467
T.K. Yau China	11	453 1.1×	400 1.0×	572 1.7×	123 0.5×	46 0.3×	18	840
E. Cellai Italy	13	168 0.4×	163 0.4×	309 0.9×	58 0.2×	154 1.0×	23	593
Samir Abdallah Hanna Brazil	12	156 0.4×	134 0.3×	150 0.5×	162 0.6×	73 0.5×	70	627
A. Richetti Switzerland	13	186 0.5×	178 0.5×	136 0.4×	126 0.5×	65 0.4×	40	569
É. Teissier France	15	387 1.0×	325 0.8×	43 0.1×	448 1.7×	289 2.0×	35	858
Vilija N. Avizonis United States	11	300 0.8×	230 0.6×	354 1.1×	150 0.6×	45 0.3×	11	711
Phyllis J. Ager United States	10	205 0.5×	177 0.5×	119 0.4×	85 0.3×	79 0.5×	11	420
Linda Sciuto United States	9	245 0.6×	266 0.7×	40 0.1×	445 1.7×	280 1.9×	16	725
Ashwini Budrukkar India	15	204 0.5×	166 0.4×	201 0.6×	171 0.6×	61 0.4×	29	774

Countries citing papers authored by H. Bartelink

Since Specialization

Citations

This map shows the geographic impact of H. Bartelink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Bartelink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Bartelink more than expected).

Fields of papers citing papers by H. Bartelink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Bartelink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Bartelink. The network helps show where H. Bartelink may publish in the future.

Co-authorship network of co-authors of H. Bartelink

This figure shows the co-authorship network connecting the top 25 collaborators of H. Bartelink. A scholar is included among the top collaborators of H. Bartelink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Bartelink. H. Bartelink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Struikmans, H., Sandra Collette, W. Van den Bogaert, et al.. (2014). 6LBA The benefit of regional irradiation in stage I–III breast cancer: 10 years results of the EORTC ROG and BCG phase III trial 22922/10925. European Journal of Cancer. 50. S3–S3. 8 indexed citations

Leij, Feike R. van der, et al.. (2013). Abstract P5-14-05: Preoperative accelerated partial breast irradiation (PAPBI) trial: First results on acute toxicity, complications and cosmetic results. Cancer Research. 73(24_Supplement). P5–14. 1 indexed citations

Poortmans, P., Alain Fourquet, Laurence Collette, et al.. (2010). 6N Irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer: state of the day of EORTC phase III trial 22922/10925 with 4004 patients. European Journal of Cancer Supplements. 8(3). 54–54. 6 indexed citations

Klaase, Joost M., et al.. (2007). [A solitary sternal lesion found by skeletal scintigraphy following treatment for breast carcinoma].. PubMed. 151(35). 1909–14. 1 indexed citations

Borger, Jacques & H. Bartelink. (2006). Does the sequence of radiotherapy and chemotherapy in breast-conserving therapy influence outcome?. PubMed. 2(1). 19–20.

Valentini, Vincenzo, Bengt Glimelius, Bruce D. Minsky, et al.. (2005). The multidisciplinary rectal cancer treatment: Main convergences, controversial aspects and investigational areas which support the need for an European Consensus. Radiotherapy and Oncology. 76(3). 241–250. 40 indexed citations

Poortmans, P., H. Bartelink, H. Struikmans, et al.. (2004). The influence of the boost technique on local control in breast conserving treatment in the EORTC ‘boost versus no boost’ trial. European Journal of Cancer Supplements. 2(3). 148–148. 18 indexed citations

Verheij, Marcel, Stefan R. Vink, J. H. M. Schellens, et al.. (2004). Phase I study of combined treatment with the oral alkyl-lysophospholipid (ALP) Perifosine and radiation in patients with advanced solid tumors. Journal of Clinical Oncology. 22(14_suppl). 3064–3064. 2 indexed citations

Bartelink, H.. (2003). Radiotherapy to the conserved breast, chest wall, and regional nodes: Is there a standard?. The Breast. 12. S9–S10. 2 indexed citations

10.

Valdés-Olmos, R.A., Diederick De Jong, Shuraila F. Zerp, et al.. (2003). 710 In vivo assessment of radiation induced apoptosis in follicular lymphoma patients by 99mTc-Annexin V scintigraphy. European Journal of Cancer Supplements. 1(5). S214–S214. 1 indexed citations

11.

Bartelink, H., P Poortmans, Jacques Borger, et al.. (2002). Minder lokale recidieven van borstkanker door extra lokale bestralingsdosis na mammasparende chirurgie: 5-jaarsresultaten van een klinische trial. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 146(9). 416–423. 1 indexed citations

12.

Leeuw, Irma M. Verdonck‐de, et al.. (2000). Consequences of voice impairment in daily-life for patients following radiotherapy for early glottic cancer: voice quality, vocal function, and vocal performance.I.J.. 44(5). 1071–1078. 3 indexed citations

13.

Bartelink, H., Alain Fourquet, Barbara Fowble, et al.. (1998). Postmastectomy radiotherapy: questions for the twenty-first century.. Journal of Clinical Oncology. 16(8). 2886–2889. 70 indexed citations

14.

Bartelink, H., F. Roelofsen, Jean-François Bosset, et al.. (1996). 103 Radiotherapy with concomitant chemotherapy superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the EORTC radiotherapy and gastrointestinal tract cooperative groups. International Journal of Radiation Oncology*Biology*Physics. 36(1). 210–210. 9 indexed citations

15.

Horenblas, Simon, et al.. (1996). [Internal radiotherapy in prostatic carcinoma; disappointing long-term results of retropubic Iodine-125 implantation].. PubMed. 140(37). 1855–9. 2 indexed citations

16.

Aleman, Berthe M.P., H. Bartelink, & Leonard L. Gunderson. (1995). The current role of radiotherapy in colorectal cancer. European Journal of Cancer. 31(7-8). 1333–1339. 19 indexed citations

17.

Bosset, J.-F., É. Pélissier, J.J. Pavy, et al.. (1994). Plea for a preoperative adjuvant approach in the management of rectal cancer. International Journal of Radiation Oncology*Biology*Physics. 29(1). 205–208. 9 indexed citations

18.

Bartelink, H., Emmanuel van der Schueren, M. van Glabbeke, & M. Piérart. (1991). The conservative management of breast carcinoma by tumourectomy and radiotherapy: an EORTC phase III study (22881/10882). Radiotherapy and Oncology. 22(4). v–v. 6 indexed citations

19.

Bartelink, H.. (1988). Combined modality treatment for primary tumor.. PubMed. 247–51. 2 indexed citations

20.

Peterse, Johannes L., J.A. van Dongen, & H. Bartelink. (1988). Recurrence of breast carcinoma after breast conserving treatment.. PubMed. 14(2). 123–6. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact